OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2411-2415
Open Access | Times Cited: 23

Showing 23 citing articles:

SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 67

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33

DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 923-936
Closed Access | Times Cited: 22

Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 14

Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28

Interaction of bioactive drugs, Glimepiride and Sitagliptin with copper clusters: DFT, SERS, docking and MD analyses
Jamelah S. Al-Otaibi, Y. Sheena Mary, Fazli Sattar, et al.
Journal of the Indian Chemical Society (2025), pp. 101712-101712
Closed Access

Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes
Naif H. Ali, Nourah Alhamdan, Hayder M. Al‐kuraishy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1985-1995
Closed Access | Times Cited: 12

Dantrolene and ryanodine receptors in COVID‐19: The daunting task and neglected warden
Luay Alkazmi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 5, pp. 335-352
Closed Access | Times Cited: 11

SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10

The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8

Effects of dipeptidyl peptidase 4 inhibition on the endothelial control of the vascular tone
João Carlos Ribeiro-Silva, Vinícius Bermond Marques, Leonardo dos Santos
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C972-C980
Closed Access | Times Cited: 7

The Potential Effect of Dapsone on the Inflammatory Reactions in COVID-19: Staggering View
Hayder M. Al-Kuraishy, Ali I. Al‐Gareeb, Engy Elekhnawy, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 5, pp. 674-678
Closed Access | Times Cited: 6

The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 5

Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics
Feng Xu, Xulong Huang, Hongmei Wu, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 105001-105001
Open Access | Times Cited: 4

Salivary levels of cell cycle regulatory proteins p53, cyclin D1, CDK 4 and protein carbonylation in post COVID-19 cohort – An observational study
Naveenaa Chellapandian, Vandana Sekizhar, Agieshkumar Balakrishna Pillai, et al.
Gene Reports (2024) Vol. 37, pp. 102010-102010
Closed Access | Times Cited: 1

VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission
Ewa Pius‐Sadowska, Piotr Kulig, Anna Niedźwiedź, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17003-17003
Open Access | Times Cited: 2

Antibacterial potential of Euphorbia canariensis against Pseudomonas aeruginosa bacteria causing respiratory tract infections
Badriyah S. Alotaibi, Engy Elekhnawy, Thanaa A. El‐Masry, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 261-269
Open Access

Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus
Sina Nabiyi, Firozeh Sajedi, Alireza Zamani, et al.
Human Immunology (2024) Vol. 85, Iss. 4, pp. 110833-110833
Closed Access

Repurposing simvastatin for treatment of Klebsiella pneumoniae infections: in vitro and in vivo study
Ehssan Moglad, Engy Elekhnawy, Nuor Alanazi, et al.
Biofouling (2024), pp. 1-15
Closed Access

Unveiling the antibacterial action of ambroxol against Staphylococcus aureus bacteria: in vitro, in vivo, and in silico investigation
Ahmed Abdelaziz, Amal M. Abo-Kamar, Alaa E. Ashour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access

Page 1

Scroll to top